Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Landmark Legislation to Create NIH Center for Advancing Non-Animal Research Introduced in Congress Tuesday

After more than a year of our dedicated congressional outreach, CAARE is proud to announce that The Humane Research and Testing Act of 2020 has been introduced by Representatives Alcee Hastings (D-FL) and Vern Buchanan (R- FL). If passed into law, the bill will establish the National Center for Alternatives to Animals in Research under the National Institutes of Health (NIH).


News provided by

CAARE

Oct 22, 2020, 10:45 ET

Share this article

Share toX

Share this article

Share toX

Lung Chip
Lung Chip

WASHINGTON, Oct. 22, 2020 /PRNewswire-PRWeb/ -- A New York-based nonprofit group, CAARE, that led the drive to create legislation to promote "cutting-edge methods" of research superior to animal-based testing, today lauded the announcement that the "Humane Research and Testing Act of 2020" has been introduced in Congress.

Landmark bipartisan legislation to promote and fund scientifically advanced, human-relevant, non-animal methods through the establishment of a dedicated center under the National Institute of Health (NIH) was introduced here Tuesday (Oct. 20) by Congressional members Alcee Hastings (D-FL) and Vern Buchanan (R-FL).

“CAARE is grateful to Representatives Hastings and Buchanan for introducing this legislation that has great promise to change the current paradigm of routine use of animals in laboratories when there are available alternatives, by establishing a center exclusively for that purpose.”

Post this

Barbara Stagno, president of Citizens for Alternatives to Animal Research & Experimentation, commends the effort, noting: "CAARE is grateful to Representatives Hastings and Buchanan for introducing this legislation that has great promise to change the current paradigm of routine use of animals in laboratories when there are available alternatives, and gives real impetus to reducing animals by establishing a center exclusively for that purpose."

The "Humane Research and Testing Act of 2020" would create a "dedicated center under the National Institutes of Health (NIH) to provide resources, funding and training to advance humane, cost-effective, and scientifically suitable non-animal methods," Stagno added.

Because the exact number of animals used in U.S. research is unknown, ranging between 17 million and 100 million annually, the "Humane Research and Testing Act of 2020" is also designed to obtain that data, and requires the NIH to outline a plan for reducing those numbers.

Congressman Hastings, the leading sponsor points out: "As science and medicine advance, we have a better understanding of the relevancy and benefits of animal-based medical research and testing on human health outcomes. We are finding methods that can better predict human results without the needless suffering of animals. This legislation will not just reduce animal testing and research but will ultimately improve medical treatments for humans as they are developed from beginning to end primarily with test subjects that replicate human biology and physiology."

CAARE is excited that the bill has received many influential endorsements including the Jane Goodall Institute, Cruelty Free International, Vanda Pharmaceuticals and Dr. Donald Ingber MD, PhD, one of the pioneers in developing organs-on-chips, a game-changing technology for replacing animals.

"I have watched for decades as millions of animals have been used in experiments of every sort that have led to insufficient knowledge gained for human medicine," said Dr. Jane Goodall, DBE, Founder, the Jane Goodall Institute & UN Messenger of Peace. "We now have the opportunity to go in a more promising direction, based on modern knowledge and innovative technologies that open up a new humane pathway for research."

Dr. Don Ingber, chaired professor at Harvard's Medical and Engineering Schools and Founding Director of its Wyss Institute for Biologically Inspired Engineering expounds, "We are reaching a tipping point in the field of in vitro human emulation technologies where they are able to recapitulate human physiology and disease states, as well as response to drugs, radiation, and toxins. A new NIH Center focused on meeting this goal would benefit this field, save animal lives, and expedite the development of more effective and safer therapies."

Cruelty Free International is one of the world's longest standing and most respected animal protection organizations and has initiated and influenced legislation around the world to eliminate animal testing and advance humane science. Monica Engebretson, Cruelty Free International's Head of Public Affairs for North America said "The need for cost-effective and reliable tools for the development of medicines and treatments has led to a wealth of 'new approach methodologies' that focus on human biology and utilize modern technologies without the use of animals. Recent global events have highlighted the need for continued investment in these modern approaches to confront public health challenges."

Citizens for Alternatives to Animal Research & Experimentation is a national 501(c)(3) non-profit organization, established to highlight and promote research without animals. CAARE's mission is to reduce animal suffering by disseminating information about the power and progress of research without animals.

SOURCE CAARE

Related Links

http://www.caareusa.org

Modal title

Mouse getting injected in a lab.
Mouse getting injected in a lab.
Logo
Logo
Mouse getting injected in a lab. Logo

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.